Dinoprostone vaginal slow-release system (Propess®) compared to expectant management in the active treatment of premature rupture of the membranes at term: impact on maternal and fetal outcomes

Background. Retrospective study of 744 women at the Virgen del Camino Hospital in Pamplona concerning two variants for the active treatment of premature rupture of the membranes (PROM). The main purpose of the study was to assess the differences between two variants for the active treatment of PROM at term in pregnant women with negative vaginal-rectal culture screening for Group B Streptococci, and a Bishop test of 4 or less on admission. Methods. Retrospective study of 744 patients with single pregnancy at term, PROM, and Bishop test